charles chong: Live & Latest News Updates : Vimarsana.com

CN Bio Raises $21 Million USD in First Close of Series B Investment Round

Asia Major: Investors back CN Bio's $21m Series B first close

VC investors from China and Hong Kong have backed the first close of a $21 million Series B round for Cambridge-based Life Science company CN Bio. Beijing-based Bayland Capital and founding shareholder CN Innovations Holdings Ltd from Hong Kong are to invest $10m and $5.5m, respectively. Other serial backers have reinvested.

CN Bio raises $21 million to scale up organ-on-a-chip technology

CN Bio has raised $21 million in Series B financing to meet increasing demand for its organ-on-a-chip (OOC) solutions.

Bitcoin halving hype: How retail investors can prepare

Vietnam to export low-carbon electricity to Singapore

Vietnam will export 1.2GW of low-carbon electricity, mostly from wind power, to the island nation.

A merger reduces the number of firms in a product market – Talk Vietnam

Firms under perfectly competitive markets generally are mcq – Talk Vietnam

Corporate governance and firm performance in emerging markets evidence from turkey – Talk Vietnam

N j temporary help service firm registration – Talk Vietnam

Metacrine completes 65 million series c financing – Talk Vietnam